Skip to main content

Table 1 Description of the study population and QFT-Plus results by putative risk factors

From: Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus

Variable

N (Col-%)

QFT-Plus positive

QFT-Plus negative

P-Value

N (Row-%)

N (Row-%)

Gender

   

0.345

 Female

72 (53.7)

4 (5.6)

68 (94.4)

 

 Male

62 (46.3)

7 (11.3)

55 (88.7)

 

Age

   

0.050

 19–25 years

87 (64.9)

4 (4.6)

83 (95.4)

 

 26–39 years

47 (35.1)

7 (14.9)

40 (85.1)

 

Country of birth classified by TB-Incidence

   

0.002

  < 125:100,000

86 (64.2)

2 (2.3)

84 (97.7)

 

  ≥ 125:100,000

48 (35.8)

9 (18.8)

39 (81.3)

 

Nationality classified by WHO regions

   

<0.001

 Africa

15 (11.2)

4 (26.7)

11 (73.3)

 

 The Americas

16 (11.9)

0 (0)

16 (100)

 

 South-East Asia

20 (14.9)

3 (15.0)

17 (85.0)

 

 Europe

49 (36.6)

0 (0)

49 (100)

 

 Eastern Mediterranean

20 (14.9)

0 (0)

20 (100)

 

 Western Pacific

14 (10.4)

4 (28.6)

10 (71.4)

 

Time living in Germany

   

0.808

  < 2 years

53 (39.6)

4 (7.5)

49 (92.5)

 

 2–10 years

71 (53.0)

7 (9.9)

64 (90.1)

 

  > 10 years

10 (7.5)

0 (0)

10 (100)

 

Previous TB contact

   

0.007

 Yes

35 (26.1)

7 (20.0)

28 (80.0)

 

 No

99 (73.9)

4 (4.0)

95 (96.0)

 

Type of TB contact

   

0.009

 Relatives

9 (25.7)

5 (55.6)

4 (44.4)

 

 Friends/acquaintances

7 (20.0)

1 (14.3)

6 (85.7)

 

 Professional

14 (40.0)

0 (0)

14 (100)

 

 Other type

5 (14.3)

1 (20.0)

4 (80.0)

 

TB in own history

   

0.082

 Yes

1 (0.7)

1 (100)

0 (0)

 

 No

133 (99.3)

10 (7.5)

123 (92.5)

 

BCG vaccination

   

0.064*

 Yes

66 (49.3)

2 (3.0)

64 (97.0)

 

 No

18 (13.4)

3 (16.7)

15 (83.3)

 

 Unknown

50 (37.3)

6 (12.0)

44 (88.0)

 

Previous TST

   

0.306

 Positive

11 (8.2)

2 (18.2)

9 (81.8)

 

 Negative

18 (13.4)

0 (0)

18 (100)

 

 Unknown

6 (4.5)

0 (0)

6 (100)

 

 No TST

99 (73.9)

9 (9.1)

90 (90.9)

 

Study subject

   

0.350

 Medicine

47 (35.1)

5 (10.6)

42 (89.4)

 

 Engineering

49 (36.6)

3 (6.1)

46 (93.9)

 

 Natural sciences

21 (15.7)

3 (14.3)

18 (85.7)

 

 Other subject

17 (12.7)

0 (0)

17 (100)

 
  1. *For BCG vaccination variable, P-Value was calculated between participants whose BCG status was known